EU Law and Life Sciences
Peter BOGAERT Damien GERADIN Editors
Robin BLANEY
Jennifer BOUDET
Miranda COLE
Michael CLANCY
Sarah FOREST
Laurie-Anne GRELIER
Christos MALAMATARIS
John RUPP
Jennifer SAPERSTEIN
Henriette (Jetty) TIELEMANS
Nicoleta TUOMINEN
Kristof VAN QUATHEM
John WILEUR
GO TO TABLE OF CONTENTS EU LAW AND LIFE SCIENCES
Editors Peter Bogaert Damien Geradin
© Institute of Competition Law, 2014
GO TO TABLE OF CONTENTS
EU Law and LifE SciEncES All rights reserved. No photocopying: copyright licenses do not apply. situation. Legal advice should always be sought before taking any legal action based on the information provided. The publisher accepts no responsibility for any acts or omissions contained herein. Enquiries concerning reproduction should be sent to the Institute of Competition Law, at the address below.
Copyright © 2014 by Institute of Competition Law 60 Broad Street, Suite 3502, NY 10004 www.concurrences.com [email protected]
Printed in the United States of America
First Printing, 2014 ISBN 978-1-939007-421
Publisher’s Cataloging-in-Publication (Provided by Quality Books, Inc.)
EU law and life sciences / editors, Peter Bogaert, Damien Geradin. pages cm Includes bibliographical references and index. LCCN 2013956306 ISBN 9781939007421 ISBN 9781939007445
1. Life sciences--Law and legislation--European Economic Community countries. I. Bogaert, Peter. II. Geradin, Damien.
KJE6172.E9 2014 349.24 QBI13-600305
Cover and book design by Yves Buliard, www.ybgraphic.fr
GO TO TABLE OF CONTENTS PREFACE
Everyone with an interest in the life sciences sector must have at least a basic knowledge of the European Union legal and regulatory system. The EU is the single largest market for medicines and authorities in the member states still play a major role in regulating pharmaceuticals and medical devices, many of the most important issues are now decided at the EU level, by the European Medi- cines Agency, the European Commission, Parliament and Council, the courts of the European Union and other EU institutions.
This book provides a detailed description of the principles of EU law, regulation and policy that most directly affect the pharmaceutical and medical device sectors. It describes systems for control of market entry; periods of regulatory and patent protection; regulation of advertising and promotion; - tion, parallel trade, life cycle management and pricing and merger control; protection of personal data; which combines experts in all relevant areas of law and regulation in major jurisdictions around the world.